Claypoole Robert E — SEC Form 4 filings
SEC reporting owner CIK 2005474. 5 Form 4 filings on record with FilingPulse; latest filed 2026-03-17.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-01-12 to 2026-03-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 28,786 shares, $261,953 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 28,786 shares @ $9.10 ($261,953) in Bioventus Inc., filed 2025-01-14.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bioventus Inc. (BVS) | President and CEO, Director | 5 | — | 1 leg · 28,786 sh · $261,953 | 14 |
Form 4 filings — Claypoole Robert E
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-17 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 33,500 @ $0 · Tax withholding (F): 14,553 @ $8.62 · Grant/award (A): 134,000 (derivative) @ $0 · Grant/award (A): 153,000 (derivative) @ $0 · Grant/award (A): 278,000 (derivative) @ $0 · Grant/award (A): 309,000 (derivative) @ $0 · +1 more | EDGAR |
| 2026-01-13 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 93,750 @ $0 · Tax withholding (F): 41,717 @ $8.03 · Option exercise (M): 93,750 (derivative) @ $0 | EDGAR |
| 2025-01-14 | 4 | Bioventus Inc. (BVS) | Sale (S): 28,786 @ $9.10 | EDGAR |
| 2025-01-13 | 4 | Bioventus Inc. (BVS) | Option exercise (M): 93,750 @ $0 · Option exercise (M): 93,750 (derivative) @ $0 | EDGAR |
| 2024-01-12 | 4 | Bioventus Inc. (BVS) | Grant/award (A): 375,000 (derivative) @ $0 · Grant/award (A): 850,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2005474 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →